# North South Ventures

> North South Ventures is a VC fund backing Health Care and Biotechnology. See 29 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: San Francisco, United States
- Total investments: 29
- Last investment: Dec 2025
- Lead investor: 10%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/north-south-ventures/about/
- X (Twitter): https://twitter.com/NorthSouthVC
- Website: https://www.northsouthvc.com/

North South Ventures is a cross-border venture capital fund that invests in early stage med companies. We are co-located in academic med superclusters (Stanford/UCSF and University of Toronto). As a team, we have invested in over 350 medical portfolio companies and 40+ FDA approvals in the biotech, med device, and digital health/AIspaces with $4B+ in cumulative funding and three multi billion dollar IPOs since 2012.

## Contacts

5 contacts available for North South Ventures. Shizune tracks 2 team members at North South Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/north-south-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 17 | 59% |
| Biotechnology | 12 | 41% |
| Medical | 9 | 31% |
| Artificial Intelligence | 5 | 17% |
| Therapeutics | 4 | 14% |

27 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 18 | 62% |
| Series A | 4 | 14% |
| Pre-Seed | 2 | 7% |
| Funding Round | 2 | 7% |
| Convertible Note | 1 | 3% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 19 | 66% |
| Spain | 1 | 3% |
| Canada | 1 | 3% |
| France | 1 | 3% |
| United Kingdom | 1 | 3% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| David Naylor | Executive | 2 | https://shizune.co/investors/profile/david-naylor-adb2 |
| Paul Kudlow | Co-Founder, General Partner | 0 | https://shizune.co/investors/profile/paul-kudlow |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Lucis | Function Health for Europe | $8.5M | Seed | Dec 16, 2025 |  |
| Noetik | Noetik is an AI-native biotechnology company. Noetik leverages in advanced machine learning methods to discover and develop cancer immunotherapies. | $40M | Series A | Aug 28, 2024 |  |
| Granza Bio | Granza Bio is a company that developing cancer therapies based on human body's immune system. | $7.1M | Seed | Jul 03, 2024 |  |
| LunaJoy | LunaJoy helps women access mental care through virtual therapy, counseling, and medication management services. The company provides online women's holistic mental health counseling and therapy provided by licensed mental health counselors and therapists. It connects patients with medical providers who can virtually assess their needs andprovide a variety of care options, such as holistic therapy, psychiatry, and mental health coaching, all over the phone or via video call. LunaJoy allows users receive one on one telemedicine sessions, wellness tools, and a holistic care plan that’s designed for them, as well as 24/7 access to the company's care navigation team. | $4.2M | Seed | Apr 16, 2024 |  |
| Tiny Health | Tiny Health is the leading microbiome health platform for people tackling chronic conditions or looking to optimize overall health. Tiny Health’s Gut Health Test is the first-ever at-home gut microbiome test for pregnant moms and babies to use shotgun metagenomics, and the company now also offers tests for older children and adults, as well asVaginal Health Tests.To date, 30,000 families have trusted Tiny Health to correct imbalances in the gut and vaginal microbiome, and optimize their lifelong health. By taking evidence-based action steps from a dietary, supplement and lifestyle based on personalized results, we've helped people reduce severe symptoms and in some cases even reverse chronic conditions. Tiny Health's team includes top scientists, physicians, and microbiologists from Mayo Clinic, Johns Hopkins, Stanford, WashU, Cornell, and Harvard Medical School. For more information, visit tinyhealth.com and poweredbytiny.com | $8.5M | Series A | Mar 05, 2024 |  |
| SFA Therapeutics | SFA Therapeutics is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease - the use of microbiome-derived metabolites as drugs. | $4.5M |  | Nov 09, 2023 |  |
| SFA Therapeutics | SFA Therapeutics is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease - the use of microbiome-derived metabolites as drugs. | $4.5M | Convertible Note | Nov 09, 2023 |  |
| Cocoon Bioscience | Cocoon Bioscience helps catalyze the expansion of bottlenecked industries like cultivated meat by manufacturing performance and growth factors and specialized enzymes for individual protein, nutrition, and healthcare applications. | $2.1M |  | Nov 03, 2023 |  |
| Noetik | Noetik is an AI-native biotechnology company. Noetik leverages in advanced machine learning methods to discover and develop cancer immunotherapies. | $14M | Seed | Sep 07, 2023 |  |
| QuantumCyte | The Quantumcyte team is a highly talented group of biology and high tech commercialization experts with experience in academic, biotech, diagnostics, medical device and high tech organizations including Stanford, Intel, Thermo Fisher, Johnson and Johnson, Genentech and others. They are driven to ensure scalability and manufacturability of theirproducts. To meet the basic research needs they have forged very close relationships and collaborations with experts in the field of cancer and genomic sequencing. | $1.1M | Series A | Aug 15, 2023 |  |

10 of 29 investments shown.

## Co-investors
- [Y Combinator](https://shizune.co/investors/profile/y-combinator) — VC Fund, 13 deals together
- [Pioneer Fund](https://shizune.co/investors/profile/pioneer-fund) — VC Fund, 5 deals together
- [Asymmetry Ventures](https://shizune.co/investors/profile/asymmetry-ventures) — VC Fund, 3 deals together
- [Savantus Ventures](https://shizune.co/investors/profile/savantus-ventures) — VC Fund, 3 deals together
- [11.2 Capital](https://shizune.co/investors/profile/112capital) — VC Fund, 2 deals together
- [Ben Franklin Technology Partners of Southeastern Pennsylvania](https://shizune.co/investors/profile/ben-franklin-technology-partners-of-southeastern-pennsylvania) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [ENISA](https://shizune.co/investors/profile/enisa-2) — VC Fund
- [Inveready](https://shizune.co/investors/profile/inveready-technology-investment-group) — VC Fund
- [Angels Capital](https://shizune.co/investors/profile/angels-capital) — VC Fund

## Featured in investor lists
- [Biotechnology VC Funds in Spain](https://shizune.co/investors/biotechnology-vc-funds-spain)
- [Food and Beverage VC Funds in Spain](https://shizune.co/investors/food-and-beverage-vc-funds-spain)
- [Biotechnology Investors in Spain](https://shizune.co/investors/biotechnology-investors-spain)

## FAQ

### What does North South Ventures invest in?

North South Ventures invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed and Series A stage. Most of the 29 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact North South Ventures?

Public channels for North South Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at North South Ventures?

The team at North South Ventures includes David Naylor (Executive) and Paul Kudlow (Co-Founder, General Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co